Abstract
Five Ru(II) polypyridyl complexes [Ru(N–N)2(nfip)](ClO4)2 (N–N = dmb, 1; bpy, 2; ttbpy, 3, phen, 4, dmp, 5) were synthesized and characterized. The cytotoxic activities of the complexes against cancer SGC-7901, Eca-109, HepG2, A549, HeLa and normal LO2 cells were investigated using the MTT method. Complexes 1–4 show high cytotoxicity against SGC-7901 cells with low IC50 values of 12.4 ± 1.4, 6.7 ± 1.6, 1.3 ± 0.5 and 1.1 ± 0.4 µM, respectively. Complex 5 is active against HeLa cells with an IC50 value of 2.2 ± 0.6 µM. Among these complexes, complexes 3 and 4 exhibit higher cytotoxic activity than cisplatin toward SGC-7901 cells under identical conditions. Apoptosis was assayed using the AO/EB staining method and flow cytometry. The location of the complexes at lysosomes and mitochondria, the permeability of lysosomes, the levels of reactive oxygen species, and the changes of mitochondrial membrane potential were studied by fluorescence microscopy. The cell cycle distribution of SGC-7901 cells induced by the complexes was studied by flow cytometry. The expression of caspase-3, PARP and Bcl-2 family proteins was investigated by Western blot. The complexes were shown to accumulate in the lysosomes and then enter into the mitochondria. The mechanism demonstrates that the complexes induce apoptosis in SGC-7901 cells through three pathways: (1) ROS-mediated lysosomal–mitochondrial dysfunction; (2) inhibition of PI3K/AKT/mTOR pathway; and (3) DNA damage and inhibition of the cell growth at G0/G1 or S phase.
Similar content being viewed by others
References
Boerner LJ, Zaleski JM (2005) Curr Opin Chem Biol 9:135–144
Palermo G, Magistrato A, Riedel T, Von Erlach T, Davey CA, Dyson PJ, Rothlisberger U (2015) ChemMedChem 11:1199–1210
Markman M (2003) Expert Opin Drug Saf 2:597–607
Bruijnincx PC, Sadler PJ (2008) Curr Opin Chem Biol 12:197–206
Chen JC, Peng F, Zhang Y, Li BJ, She J, Jia XM, Zou ZL, Chen M, Chen LM (2017) Eur J Med Chem 140:104–117
Kaulage MH, Maji B, Pasadi S, Buattacharya S, Muniyappa K (2017) Eur J Med Chem 139:1016–1029
Wan D, Tang B, Wang YJ, Guo BH, Yin H, Yi QY, Liu YJ (2017) Eur J Med Chem 139:180–190
Zeng CC, Lai SH, Yao JH, Zhang C, Yin H, Li W, Han BJ, Liu YJ (2016) Eur J Med Chem 122:118–126
Wang JQ, Kou JF, Zhao ZZ, Qiu KQ, Chao H (2017) Inorg Chem Front 4:1003–1012
Cao Q, Li Y, Freisinger E, Qin PZ, Sigel RO, Mao ZW (2017) Inorg Chem Front 4:10–32
Deepika N, Kumar YP, Devi CS, Reddy PV, Srishailam A, Satyanarayana S (2013) J Biol Inorg Chem 18:751–766
Zhang C, Han BJ, Zeng CC, Tang B, Wan D, Jiang GB, Liu YJ (2016) J Inorg Biochem 157:62–72
Sainuddin T, McCain J, Pinto M, Yin H, Gibson J, Hetu M, McFarland SA (2016) Inorg Chem 55:83–95
Oliveira KM, Liany LD, Corrêa RS, Deflon VM, Comineth MR, Bitastia AA (2017) J Inorg Biochem 176:66–76
Chen WX, Song XD, Hu SF, Sun J, Chen JX, Wu T, Mao ZW (2016) J Inorg Biochem 64:91–98
Milutinović MM, Rilak A, Bratsos L, Klisurić O, Vraneŝ M, Gligorijević N, Radelović S, Bugarčić ŻD (2017) J Inorg Biochem 169:1–12
Li GY, Sun LL, Ji LN, Chao H (2016) Dalton Trans 45:13261–13276
Du KJ, Liang JW, Kou JF, Qian C, Ji LN, Chao H (2014) Dalton Trans 43:17303–17316
Tang B, Han BJ, Wan D, Lai SH, Wang XZ, Zhang C, Zeng CC, Liu YJ (2017) Transit Met Chem 42:373–396
Li W, Jiang GB, Yao JH, Wang XZ, Wang J, Han BJ, Xie YY, Lin GJ, Huang HL, Liu YJ (2014) J Photochem Photobiol B Biol 140:94–104
Wan D, Lai SH, Zeng CC, Zhang C, Tang B, Liu YJ (2017) J Inorg Biochem 173:1–11
Lai SH, Jiang GB, Yao JH, Li W, Han BJ, Zhang C, Zeng CC, Liu YJ (2015) J Inorg Biochem 152:1–9
Cao WQ, Zheng WJ, Chen TF (2015) Sci Rep 5:9157
Deepika N, Devi CS, Kumar YP, Reddy KL, Reddy PV, Kumar DA, Singh SS, Satyanarayana S (2016) J Photochem Photobiol B Biol 160:142–153
Juris A, Balzani V, Barigelletti F, Campagna S, Belser P, Von Zelewsky A (1988) Coord Chem Rev 84:85–277
Habtemariam A, Melchart M, Fernandez R, Parsons S, Oswald IDH, Parkin A, Fabbiani FPA, Davidson JE, Dawson AE, Aird RE, Jodrell DI, Sadler PJ (2006) J Med Chem 49:6858–6868
Sun B, Wang YC, Qian C, Chu J, Liang SM, Chao H, Ji LN (2010) J Mol Struct 963:153–159
Sullivan BP, Salmon DJ, Meyer TJ (1978) Inorg Chem 17:3334–3341
Collin JP, Sauvage JP (1986) Inorg Chem 25:135–141
Mosmann T (1983) J Immunol Methods 65:55–63
Lo KK, Lee TK, Lau JS, Poon WL, Cheng SH (2008) Inorg Chem 47:200–208
Alapetite C, Wachter T, Sage E, Moustacchi E (1986) Int J Radiat Biol 69:359–369
Franco JL, Posser T, Dunkley PR (2009) Free Radic Biol Med 7:449–457
Wang X, Nguyen DM, Yanez CO, Rodriguez L, Ahn HY, Bondar MV, Belfield KD (2010) J Am Soc Chem 132:12237–12239
Chang Y, Li Y, Ye N, Guo X, Li Z, Sun G, Sun Y (2016) Apoptosis 21:977–996
Zhong Y, Jin C, Gan J, Wang X, Shi Z, Xia X, Peng X (2017) Toxicon 137:106–113
Yugandhar D, Nayak VL, Archana S, Shekar KC, Srivastava AK (2015) Eur J Med Chem 101:348–357
Prasad S, Gupta SC, Tyagi AK (2017) Cancer Lett 387:95–105
Ozben T (2007) J Pharm Sci 96:2181–2196
Shadel GS, Horvath TL (2015) Cell 163:560–569
Gammella E, Recalcati S, Cairo G (2016) Oxid Med Cell Longev 2016:8629024
Diebold L, Chandel NS (2016) Free Radic Biol Med 100:86–93
Zorov DB, Juhaszova M, Sollott SJ (2014) Physiol Rev 94:909–950
Shen HM, Liu ZG (2006) Free Radic Biol Med 40:928–939
Dröge W (2002) Physiol Rev 82:47–95
Romagnoli A, Aguiari P, De SD, Leo S, Marchi S, Rimessi A, Zecchini E, Pinton P, Rizzuto R (2007) Endoplasmic reticulum/mitochondria calcium cross-talk. Novartis Found Symp 287:122–131
Duszyński J, Kozieł R, Brutkowski W, Szczepanowska J, Zabłocki K (2006) BBA Bioenerg 1757:380–387
Trump BF, Berezesky IK (1995) FASEB J 9:219–228
Orrenius S, Zhivotovsky B, Nicotera P, Orrenius S, Zhivotovsky B, Nicotera P (2003) Nat Rev Mol Cell Biol 4:552–565
Renz A, Berdel WE, Kreuter M, Belka C, Schulze-Osthoff K, Los M (2001) Blood 98:1542–1548
Osaka A, Hasegawa H, Yamada Y, Yanagihara K, Hayashi T, Mine M, Aoyama M, Sawada T, Kamihira SA (2009) J Cancer Res Clin Oncol 135:371–377
Alghamian Y, Abou AG, Murad H, Madania A (2017) Adv Med Sci 62:330–337
Okada H, Mak TW (2004) Nat Rev Cancer 4:592–603
Tiwari RV, Parajuli P, Sylvester PW (2015) Mol Cell Biochem 408:1–15
Biederbick A, Kern HF, Elsässer HP (1995) Eur J Cell Biol 66:3–14
Rubinsztein DC, Gestwicki JE, Murphy LO, Klionsky DJ (2007) Nat Rev Drug Discov 6:304–312
Duriez PJ, Shah GM (1997) Biochem Cell Biol 75:337–349
Hara K, Kasahara E, Takahashi N, Konishi M, Inoue J, Jikumaru M, Kubo S, Okamura H, Sato E, Inoue M (2011) J Pharmacol Exp Ther 337:838–845
Danial NN, Korsmeyer SJ (2004) Cell 116:205–219
Kilic U, Caglayan AB, Beker MC, Gunal MY, Caglayan B, Yalcin E, Kelestemur T, Gundogdu RZ, Yulug B, Yılmaz B, Kerman BE, Kilic E (2017) Redox Biol 12:657–665
Tapia-Limonchi R, Cahuana GM, Caballano-Infantes E, Salguero-Aranda C, Beltran-Povea A, Hitos AB, Hmadcha A, Martin F, Soria B, Bedoya FJ, Tejedo JR (2016) J Cell Biochem 117:2078–2088
Song G, Ouyang G, Bao S (2005) J Cell Mol Med 9:59–71
Acknowledgements
This work was supported by the National Nature Science Foundation of China (No. 21877018) and the Natural Science Foundation of Guangdong Province (No. 2016A030313728).
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Yi, QY., Wang, YJ., He, M. et al. Induction of apoptosis in SGC-7901 cells by ruthenium(II) complexes through ROS-mediated lysosome–mitochondria dysfunction and inhibition of PI3K/AKT/mTOR pathways. Transit Met Chem 44, 187–205 (2019). https://doi.org/10.1007/s11243-018-0283-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11243-018-0283-8